palonosetron sandoz 0.25 mg / 5 ml soluzione iniettabile
sandoz pharmaceuticals ag - palonosetronum - soluzione iniettabile - palonosetronum 0.05 mg ut palonosetroni hydrochloridum, mannitolum, dinatrii edetas, natrii citras dihydricus, acidum citricum monohydricum, natrii hydroxidum, acidum hydrochloridum, aqua ad iniectabile q.s. ad solutionem pro 1 ml corresp. natrium 0.93 mg. - antiemetico - synthetika
palonosetron accord 0,25 mg/5 ml soluzione iniettabile
accord healthcare ag - palonosetronum - soluzione iniettabile - palonosetronum 0.05 mg ut palonosetroni hydrochloridum, mannitolum, acidum citricum monohydricum, natrii citras dihydricus, dinatrii edetas, natrii hydroxidum q.s. ad ph, acidum hydrochloridum q.s. ad ph, aqua ad iniectabile q.s. ad solutionem pro 1 ml corresp. natrium 0.6 mg. - antiemetico - synthetika
palonosetron kalceks
as kalceks - palonosetron - palonosetron
kimmtrak
immunocore ireland limited - tebentafusp - uveal neoplasms - agenti antineoplastici - kimmtrak is indicated as monotherapy for the treatment of human leukocyte antigen (hla)-a*02:01-positive adult patients with unresectable or metastatic uveal melanoma.
palonosetron labatec 0.25 mg/ 5 ml soluzione iniettabile i.v.
labatec pharma sa - palonosetronum - soluzione iniettabile i.v. - palonosetronum 0.25 mg ut palonosetroni hydrochloridum, mannitolum, dinatrii edetas, natrii citras dihydricus, acidum citricum monohydricum, natrii hydroxidum, acidum hydrochloridum, aqua ad iniectabile, ad solutionem pro 5 ml corresp. natrium max. 3.9 mg. - antiemetico - synthetika
palonosetron-teva 0.25 mg/5 ml soluzione iniettabile
teva pharma ag - palonosetronum - soluzione iniettabile - palonosetronum 0.25 mg ut palonosetroni hydrochloridum, mannitolum, dinatrii edetas, acidum citricum monohydricum, natrii citras dihydricus, natrii hydroxidum, acidum hydrochloridum, aqua ad iniectabile q.s. ad solutionem pro 5 ml corresp., natrium 5,8 mg. - antiemetico - synthetika
palonosetron reig jofre
laboratorio reig jofre, s.a. - palonosetron - palonosetron